ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Terbinafine Hydrochloride Drug Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-33W6773
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Terbinafine Hydrochloride Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Terbinafine Hydrochloride Drug Market Research Report 2025

Code: QYRE-Auto-33W6773
Report
August 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
GSK
TEVA
Dr. Reddy’s Laboratories
Cipla Ltd
Taro
Invagen Pharmaceuticals
Breckenridge Pharmaceutical
Harris Pharmaceutical
Glenmark
Orchid Healthcare
Apotex
Jilin Wantong Group
Cussess
Hubei Hengan Fulin Pharm
Xiuzheng Pharmaceutical

Terbinafine Hydrochloride Drug Market Size

The global market for Terbinafine Hydrochloride Drug was valued at US$ 665 million in the year 2024 and is projected to reach a revised size of US$ 1021 million by 2031, growing at a CAGR of 6.4% during the forecast period.

Terbinafine Hydrochloride Drug Market

Terbinafine Hydrochloride Drug Market

Terbinafine, sold under the brand name Lamisil among others, an antifungal medication used to treat pityriasis versicolor, fungal nail infections, and ringworm including jock itch and athlete"s foot. It is either taken by mouth or applied to the skin as a cream or ointment. The cream and ointment are not effective for nail infections.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Terbinafine Hydrochloride Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Terbinafine Hydrochloride Drug.
The Terbinafine Hydrochloride Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Terbinafine Hydrochloride Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Terbinafine Hydrochloride Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Terbinafine Hydrochloride Drug Market Report

Report Metric Details
Report Name Terbinafine Hydrochloride Drug Market
Accounted market size in year US$ 665 million
Forecasted market size in 2031 US$ 1021 million
CAGR 6.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Fingernail Infection
  • Toenail Infection
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, GSK, TEVA, Dr. Reddy's Laboratories, CIPLA LTD, TARO, InvaGen Pharmaceuticals, Breckenridge Pharmaceutical, Harris Pharmaceutical, Glenmark, Orchid Healthcare, APOTEX, Jilin Wantong Group, Cussess, Hubei Hengan Fulin Pharm, Xiuzheng Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Terbinafine Hydrochloride Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Terbinafine Hydrochloride Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Terbinafine Hydrochloride Drug Market growing?

Ans: The Terbinafine Hydrochloride Drug Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the Terbinafine Hydrochloride Drug Market size in 2031?

Ans: The Terbinafine Hydrochloride Drug Market size in 2031 will be US$ 1021 million.

Who are the main players in the Terbinafine Hydrochloride Drug Market report?

Ans: The main players in the Terbinafine Hydrochloride Drug Market are Novartis, GSK, TEVA, Dr. Reddy's Laboratories, CIPLA LTD, TARO, InvaGen Pharmaceuticals, Breckenridge Pharmaceutical, Harris Pharmaceutical, Glenmark, Orchid Healthcare, APOTEX, Jilin Wantong Group, Cussess, Hubei Hengan Fulin Pharm, Xiuzheng Pharmaceutical

What are the Application segmentation covered in the Terbinafine Hydrochloride Drug Market report?

Ans: The Applications covered in the Terbinafine Hydrochloride Drug Market report are Fingernail Infection, Toenail Infection, Others

What are the Type segmentation covered in the Terbinafine Hydrochloride Drug Market report?

Ans: The Types covered in the Terbinafine Hydrochloride Drug Market report are Topical, Oral

Recommended Reports

Hydrochloride Drugs

Antifungal Treatments

Pharmaceutical Ingredients

1 Terbinafine Hydrochloride Drug Market Overview
1.1 Product Definition
1.2 Terbinafine Hydrochloride Drug by Type
1.2.1 Global Terbinafine Hydrochloride Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Topical
1.2.3 Oral
1.3 Terbinafine Hydrochloride Drug by Application
1.3.1 Global Terbinafine Hydrochloride Drug Market Value by Application (2024 VS 2031)
1.3.2 Fingernail Infection
1.3.3 Toenail Infection
1.3.4 Others
1.4 Global Terbinafine Hydrochloride Drug Market Size Estimates and Forecasts
1.4.1 Global Terbinafine Hydrochloride Drug Revenue 2020-2031
1.4.2 Global Terbinafine Hydrochloride Drug Sales 2020-2031
1.4.3 Global Terbinafine Hydrochloride Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Terbinafine Hydrochloride Drug Market Competition by Manufacturers
2.1 Global Terbinafine Hydrochloride Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Terbinafine Hydrochloride Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Terbinafine Hydrochloride Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Terbinafine Hydrochloride Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Terbinafine Hydrochloride Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Terbinafine Hydrochloride Drug, Product Type & Application
2.7 Global Key Manufacturers of Terbinafine Hydrochloride Drug, Date of Enter into This Industry
2.8 Global Terbinafine Hydrochloride Drug Market Competitive Situation and Trends
2.8.1 Global Terbinafine Hydrochloride Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Terbinafine Hydrochloride Drug Players Market Share by Revenue
2.8.3 Global Terbinafine Hydrochloride Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Terbinafine Hydrochloride Drug Market Scenario by Region
3.1 Global Terbinafine Hydrochloride Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Terbinafine Hydrochloride Drug Sales by Region: 2020-2031
3.2.1 Global Terbinafine Hydrochloride Drug Sales by Region: 2020-2025
3.2.2 Global Terbinafine Hydrochloride Drug Sales by Region: 2026-2031
3.3 Global Terbinafine Hydrochloride Drug Revenue by Region: 2020-2031
3.3.1 Global Terbinafine Hydrochloride Drug Revenue by Region: 2020-2025
3.3.2 Global Terbinafine Hydrochloride Drug Revenue by Region: 2026-2031
3.4 North America Terbinafine Hydrochloride Drug Market Facts & Figures by Country
3.4.1 North America Terbinafine Hydrochloride Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Terbinafine Hydrochloride Drug Sales by Country (2020-2031)
3.4.3 North America Terbinafine Hydrochloride Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Terbinafine Hydrochloride Drug Market Facts & Figures by Country
3.5.1 Europe Terbinafine Hydrochloride Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Terbinafine Hydrochloride Drug Sales by Country (2020-2031)
3.5.3 Europe Terbinafine Hydrochloride Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Terbinafine Hydrochloride Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Terbinafine Hydrochloride Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Terbinafine Hydrochloride Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Terbinafine Hydrochloride Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Terbinafine Hydrochloride Drug Market Facts & Figures by Country
3.7.1 Latin America Terbinafine Hydrochloride Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Terbinafine Hydrochloride Drug Sales by Country (2020-2031)
3.7.3 Latin America Terbinafine Hydrochloride Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Terbinafine Hydrochloride Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Terbinafine Hydrochloride Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Terbinafine Hydrochloride Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Terbinafine Hydrochloride Drug Sales by Type (2020-2031)
4.1.1 Global Terbinafine Hydrochloride Drug Sales by Type (2020-2025)
4.1.2 Global Terbinafine Hydrochloride Drug Sales by Type (2026-2031)
4.1.3 Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2020-2031)
4.2 Global Terbinafine Hydrochloride Drug Revenue by Type (2020-2031)
4.2.1 Global Terbinafine Hydrochloride Drug Revenue by Type (2020-2025)
4.2.2 Global Terbinafine Hydrochloride Drug Revenue by Type (2026-2031)
4.2.3 Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2020-2031)
4.3 Global Terbinafine Hydrochloride Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Terbinafine Hydrochloride Drug Sales by Application (2020-2031)
5.1.1 Global Terbinafine Hydrochloride Drug Sales by Application (2020-2025)
5.1.2 Global Terbinafine Hydrochloride Drug Sales by Application (2026-2031)
5.1.3 Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2020-2031)
5.2 Global Terbinafine Hydrochloride Drug Revenue by Application (2020-2031)
5.2.1 Global Terbinafine Hydrochloride Drug Revenue by Application (2020-2025)
5.2.2 Global Terbinafine Hydrochloride Drug Revenue by Application (2026-2031)
5.2.3 Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2020-2031)
5.3 Global Terbinafine Hydrochloride Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Terbinafine Hydrochloride Drug Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Terbinafine Hydrochloride Drug Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Company Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 TEVA Terbinafine Hydrochloride Drug Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Dr. Reddy's Laboratories
6.4.1 Dr. Reddy's Laboratories Company Information
6.4.2 Dr. Reddy's Laboratories Description and Business Overview
6.4.3 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product Portfolio
6.4.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.5 CIPLA LTD
6.5.1 CIPLA LTD Company Information
6.5.2 CIPLA LTD Description and Business Overview
6.5.3 CIPLA LTD Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CIPLA LTD Terbinafine Hydrochloride Drug Product Portfolio
6.5.5 CIPLA LTD Recent Developments/Updates
6.6 TARO
6.6.1 TARO Company Information
6.6.2 TARO Description and Business Overview
6.6.3 TARO Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 TARO Terbinafine Hydrochloride Drug Product Portfolio
6.6.5 TARO Recent Developments/Updates
6.7 InvaGen Pharmaceuticals
6.7.1 InvaGen Pharmaceuticals Company Information
6.7.2 InvaGen Pharmaceuticals Description and Business Overview
6.7.3 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product Portfolio
6.7.5 InvaGen Pharmaceuticals Recent Developments/Updates
6.8 Breckenridge Pharmaceutical
6.8.1 Breckenridge Pharmaceutical Company Information
6.8.2 Breckenridge Pharmaceutical Description and Business Overview
6.8.3 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
6.8.5 Breckenridge Pharmaceutical Recent Developments/Updates
6.9 Harris Pharmaceutical
6.9.1 Harris Pharmaceutical Company Information
6.9.2 Harris Pharmaceutical Description and Business Overview
6.9.3 Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Harris Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
6.9.5 Harris Pharmaceutical Recent Developments/Updates
6.10 Glenmark
6.10.1 Glenmark Company Information
6.10.2 Glenmark Description and Business Overview
6.10.3 Glenmark Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Glenmark Terbinafine Hydrochloride Drug Product Portfolio
6.10.5 Glenmark Recent Developments/Updates
6.11 Orchid Healthcare
6.11.1 Orchid Healthcare Company Information
6.11.2 Orchid Healthcare Description and Business Overview
6.11.3 Orchid Healthcare Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Orchid Healthcare Terbinafine Hydrochloride Drug Product Portfolio
6.11.5 Orchid Healthcare Recent Developments/Updates
6.12 APOTEX
6.12.1 APOTEX Company Information
6.12.2 APOTEX Description and Business Overview
6.12.3 APOTEX Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2020-2025)
6.12.4 APOTEX Terbinafine Hydrochloride Drug Product Portfolio
6.12.5 APOTEX Recent Developments/Updates
6.13 Jilin Wantong Group
6.13.1 Jilin Wantong Group Company Information
6.13.2 Jilin Wantong Group Description and Business Overview
6.13.3 Jilin Wantong Group Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Jilin Wantong Group Terbinafine Hydrochloride Drug Product Portfolio
6.13.5 Jilin Wantong Group Recent Developments/Updates
6.14 Cussess
6.14.1 Cussess Company Information
6.14.2 Cussess Description and Business Overview
6.14.3 Cussess Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Cussess Terbinafine Hydrochloride Drug Product Portfolio
6.14.5 Cussess Recent Developments/Updates
6.15 Hubei Hengan Fulin Pharm
6.15.1 Hubei Hengan Fulin Pharm Company Information
6.15.2 Hubei Hengan Fulin Pharm Description and Business Overview
6.15.3 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product Portfolio
6.15.5 Hubei Hengan Fulin Pharm Recent Developments/Updates
6.16 Xiuzheng Pharmaceutical
6.16.1 Xiuzheng Pharmaceutical Company Information
6.16.2 Xiuzheng Pharmaceutical Description and Business Overview
6.16.3 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
6.16.5 Xiuzheng Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Terbinafine Hydrochloride Drug Industry Chain Analysis
7.2 Terbinafine Hydrochloride Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Terbinafine Hydrochloride Drug Production Mode & Process Analysis
7.4 Terbinafine Hydrochloride Drug Sales and Marketing
7.4.1 Terbinafine Hydrochloride Drug Sales Channels
7.4.2 Terbinafine Hydrochloride Drug Distributors
7.5 Terbinafine Hydrochloride Drug Customer Analysis
8 Terbinafine Hydrochloride Drug Market Dynamics
8.1 Terbinafine Hydrochloride Drug Industry Trends
8.2 Terbinafine Hydrochloride Drug Market Drivers
8.3 Terbinafine Hydrochloride Drug Market Challenges
8.4 Terbinafine Hydrochloride Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
GSK
TEVA
Dr. Reddy’s Laboratories
Cipla Ltd
Taro
Invagen Pharmaceuticals
Breckenridge Pharmaceutical
Harris Pharmaceutical
Glenmark
Orchid Healthcare
Apotex
Jilin Wantong Group
Cussess
Hubei Hengan Fulin Pharm
Xiuzheng Pharmaceutical
List of Tables
 Table 1. Global Terbinafine Hydrochloride Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Terbinafine Hydrochloride Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Terbinafine Hydrochloride Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Terbinafine Hydrochloride Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Terbinafine Hydrochloride Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Terbinafine Hydrochloride Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Terbinafine Hydrochloride Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Terbinafine Hydrochloride Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Terbinafine Hydrochloride Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Terbinafine Hydrochloride Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Terbinafine Hydrochloride Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Terbinafine Hydrochloride Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Terbinafine Hydrochloride Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Terbinafine Hydrochloride Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Terbinafine Hydrochloride Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Terbinafine Hydrochloride Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Terbinafine Hydrochloride Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Terbinafine Hydrochloride Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Terbinafine Hydrochloride Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Terbinafine Hydrochloride Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Terbinafine Hydrochloride Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Terbinafine Hydrochloride Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Terbinafine Hydrochloride Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Terbinafine Hydrochloride Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Terbinafine Hydrochloride Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Terbinafine Hydrochloride Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Terbinafine Hydrochloride Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Terbinafine Hydrochloride Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Terbinafine Hydrochloride Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Terbinafine Hydrochloride Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Terbinafine Hydrochloride Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Terbinafine Hydrochloride Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Terbinafine Hydrochloride Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Terbinafine Hydrochloride Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Terbinafine Hydrochloride Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Terbinafine Hydrochloride Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Terbinafine Hydrochloride Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Terbinafine Hydrochloride Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Terbinafine Hydrochloride Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Terbinafine Hydrochloride Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Terbinafine Hydrochloride Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Terbinafine Hydrochloride Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Terbinafine Hydrochloride Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Terbinafine Hydrochloride Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Terbinafine Hydrochloride Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Terbinafine Hydrochloride Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Terbinafine Hydrochloride Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Terbinafine Hydrochloride Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis Terbinafine Hydrochloride Drug Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. GSK Terbinafine Hydrochloride Drug Product
 Table 79. GSK Recent Developments/Updates
 Table 80. TEVA Company Information
 Table 81. TEVA Description and Business Overview
 Table 82. TEVA Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. TEVA Terbinafine Hydrochloride Drug Product
 Table 84. TEVA Recent Developments/Updates
 Table 85. Dr. Reddy's Laboratories Company Information
 Table 86. Dr. Reddy's Laboratories Description and Business Overview
 Table 87. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product
 Table 89. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 90. CIPLA LTD Company Information
 Table 91. CIPLA LTD Description and Business Overview
 Table 92. CIPLA LTD Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. CIPLA LTD Terbinafine Hydrochloride Drug Product
 Table 94. CIPLA LTD Recent Developments/Updates
 Table 95. TARO Company Information
 Table 96. TARO Description and Business Overview
 Table 97. TARO Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. TARO Terbinafine Hydrochloride Drug Product
 Table 99. TARO Recent Developments/Updates
 Table 100. InvaGen Pharmaceuticals Company Information
 Table 101. InvaGen Pharmaceuticals Description and Business Overview
 Table 102. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product
 Table 104. InvaGen Pharmaceuticals Recent Developments/Updates
 Table 105. Breckenridge Pharmaceutical Company Information
 Table 106. Breckenridge Pharmaceutical Description and Business Overview
 Table 107. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product
 Table 109. Breckenridge Pharmaceutical Recent Developments/Updates
 Table 110. Harris Pharmaceutical Company Information
 Table 111. Harris Pharmaceutical Description and Business Overview
 Table 112. Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Harris Pharmaceutical Terbinafine Hydrochloride Drug Product
 Table 114. Harris Pharmaceutical Recent Developments/Updates
 Table 115. Glenmark Company Information
 Table 116. Glenmark Description and Business Overview
 Table 117. Glenmark Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Glenmark Terbinafine Hydrochloride Drug Product
 Table 119. Glenmark Recent Developments/Updates
 Table 120. Orchid Healthcare Company Information
 Table 121. Orchid Healthcare Description and Business Overview
 Table 122. Orchid Healthcare Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Orchid Healthcare Terbinafine Hydrochloride Drug Product
 Table 124. Orchid Healthcare Recent Developments/Updates
 Table 125. APOTEX Company Information
 Table 126. APOTEX Description and Business Overview
 Table 127. APOTEX Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. APOTEX Terbinafine Hydrochloride Drug Product
 Table 129. APOTEX Recent Developments/Updates
 Table 130. Jilin Wantong Group Company Information
 Table 131. Jilin Wantong Group Description and Business Overview
 Table 132. Jilin Wantong Group Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Jilin Wantong Group Terbinafine Hydrochloride Drug Product
 Table 134. Jilin Wantong Group Recent Developments/Updates
 Table 135. Cussess Company Information
 Table 136. Cussess Description and Business Overview
 Table 137. Cussess Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Cussess Terbinafine Hydrochloride Drug Product
 Table 139. Cussess Recent Developments/Updates
 Table 140. Hubei Hengan Fulin Pharm Company Information
 Table 141. Hubei Hengan Fulin Pharm Description and Business Overview
 Table 142. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product
 Table 144. Hubei Hengan Fulin Pharm Recent Developments/Updates
 Table 145. Xiuzheng Pharmaceutical Company Information
 Table 146. Xiuzheng Pharmaceutical Description and Business Overview
 Table 147. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product
 Table 149. Xiuzheng Pharmaceutical Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Terbinafine Hydrochloride Drug Distributors List
 Table 153. Terbinafine Hydrochloride Drug Customers List
 Table 154. Terbinafine Hydrochloride Drug Market Trends
 Table 155. Terbinafine Hydrochloride Drug Market Drivers
 Table 156. Terbinafine Hydrochloride Drug Market Challenges
 Table 157. Terbinafine Hydrochloride Drug Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Terbinafine Hydrochloride Drug
 Figure 2. Global Terbinafine Hydrochloride Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Terbinafine Hydrochloride Drug Market Share by Type: 2024 & 2031
 Figure 4. Topical Product Picture
 Figure 5. Oral Product Picture
 Figure 6. Global Terbinafine Hydrochloride Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Terbinafine Hydrochloride Drug Market Share by Application: 2024 & 2031
 Figure 8. Fingernail Infection
 Figure 9. Toenail Infection
 Figure 10. Others
 Figure 11. Global Terbinafine Hydrochloride Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Terbinafine Hydrochloride Drug Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Terbinafine Hydrochloride Drug Sales (2020-2031) & (K Units)
 Figure 14. Global Terbinafine Hydrochloride Drug Average Price (USD/Unit) & (2020-2031)
 Figure 15. Terbinafine Hydrochloride Drug Report Years Considered
 Figure 16. Terbinafine Hydrochloride Drug Sales Share by Manufacturers in 2024
 Figure 17. Global Terbinafine Hydrochloride Drug Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Terbinafine Hydrochloride Drug Players: Market Share by Revenue in Terbinafine Hydrochloride Drug in 2024
 Figure 19. Terbinafine Hydrochloride Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Terbinafine Hydrochloride Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Terbinafine Hydrochloride Drug Sales Market Share by Country (2020-2031)
 Figure 22. North America Terbinafine Hydrochloride Drug Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Terbinafine Hydrochloride Drug Sales Market Share by Country (2020-2031)
 Figure 26. Europe Terbinafine Hydrochloride Drug Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Terbinafine Hydrochloride Drug Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Terbinafine Hydrochloride Drug Revenue Market Share by Region (2020-2031)
 Figure 34. China Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Terbinafine Hydrochloride Drug Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Terbinafine Hydrochloride Drug Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Terbinafine Hydrochloride Drug Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Terbinafine Hydrochloride Drug Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Terbinafine Hydrochloride Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Terbinafine Hydrochloride Drug by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Terbinafine Hydrochloride Drug by Type (2020-2031)
 Figure 56. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Terbinafine Hydrochloride Drug by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Terbinafine Hydrochloride Drug by Application (2020-2031)
 Figure 59. Global Terbinafine Hydrochloride Drug Price (USD/Unit) by Application (2020-2031)
 Figure 60. Terbinafine Hydrochloride Drug Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Terbinafine Lamisil Market Research Report 2024
Global Terbinafine Hydrochloride Cream Market Research Report 2024
Global Antifungal and Ringworm Treatment Drugs Market Research Report 2025
Global Naftifine Hydrochloride Ointment Market Insights Forecast to 2030
Global Fungal Drugs for Treatment of Tinea Market Research Report 2025
Tropicamide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Onychomycosis Tinea Unguium Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Onychomycosis Drugs Market Research Report 2024
Global Amorofen Hydrochloride Liniment Market Research Report 2024
Global Terbinafine Hydrochloride Market Research Report 2024
Global Tinidazole Tablet Market Insights Forecast to 2030
Global Tindamax Market Insights Forecast to 2030
Global Epinastine Hydrochloride Ophthalmic Preparations Market Research Report 2024
Global Tavaborole Market Insights Forecast to 2030
Global Liranaftate Market Research Report 2024
Global Terbinafine Hydrochloride API Market Research Report 2024
Fungal Nail Infections Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bisdisulizole Disodium Market Research Report 2024
Trimipramine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Terbinafine Hydrochloride Spray Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions